Life Sciences

Government to continue fraud crackdown

Pharma Compliance Alert, February 18, 2009

Pharmaceutical companies can expect to see more state resources aimed at healthcare fraud enforcement, Delaware Deputy Attorney General Dan Miller, Esq., said during the Center for Business Intelligence’s Sixth Annual Pharmaceutical Compliance Congress in Washington D.C.

Healthcare fraud is an area “ripe for prosecutors to look at,” Miller said.

New allegations against pharmaceutical companies continue to arrive, says Michael Loucks, Esq., First Assistant US Attorney in Massachusetts. Some problematic conduct is trailing off, but Loucks’ office still sees some of the same questionable conduct continuing. Although investigations usually focus on past behavior, Loucks said it is “disturbing” to see the same conduct continuing in the present.

Most Popular